Aprea Therapeutics, Inc. - Common Stock, $0.001 par value per share (APRE) Institutional Ownership

CUSIP: 03836J102

13F Institutional Holders and Ownership History from Q4 2019 to Q4 2024

Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
APRE on Nasdaq
Shares outstanding
6,583,303
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 03836J102?
CUSIP 03836J102 identifies APRE - Aprea Therapeutics, Inc. - Common Stock, $0.001 par value per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Significant Owners of Aprea Therapeutics, Inc. - Common Stock, $0.001 par value per share (APRE) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HIRSCHMAN ORIN 9.9% 0% 651,747 +21% Orin Hirschman 31 Dec 2025
Sio Capital Management, LLC 5.1% $138,302 276,603 Sio Capital Management, LLC 31 Dec 2024

Institutional Holders of Aprea Therapeutics, Inc. - Common Stock, $0.001 par value per share (APRE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q4 0 $0 -$2,000 0
2024 Q3 899 $2,000 $2.22 1
2024 Q2 899 $3,000 -$669 $3.34 1
2024 Q1 999 $6,669 +$6,000 $6.68 2
2023 Q4 100 $470 $4.70 1
2023 Q3 100 $417 $4.17 1
2023 Q2 100 $315 -$13 $3.15 1
2023 Q1 103 $457 -$520,123 $4.39 2
2022 Q4 1,587,074 $520,280 -$37,678 $0.33 23
2022 Q3 1,704,277 $1,109,338 -$364,998 $0.65 23
2022 Q2 2,029,597 $1,519,025 -$805,646 $0.75 29
2022 Q1 2,418,438 $4,501,000 -$2,768,395 $1.86 38
2021 Q4 3,610,494 $10,361,000 -$8,428,012 $2.87 35
2021 Q3 4,999,711 $25,549,281 -$7,565,851 $5.11 37
2021 Q2 6,538,488 $31,906,000 -$12,001,808 $4.88 48
2021 Q1 8,932,107 $45,408,770 -$6,611,636 $5.10 64
2020 Q4 10,317,198 $50,763,750 -$96,371,442 $4.92 63
2020 Q3 16,834,877 $404,988,700 +$5,638,022 $24.06 65
2020 Q2 16,477,324 $638,906,382 +$117,351,300 $38.78 64
2020 Q1 13,469,861 $467,365,016 +$18,770,937 $34.76 50
2019 Q4 12,931,705 $591,290,000 +$460,153,003 $45.89 39